A Risk Sciences International news item posted on May 11, 2022 and last updated on May 11, 2022

Using data from the US Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System, RSI investigators collaborated on a study showing increased risks of myopericarditis – an inflammatory condition of the heart muscle – following mRNA COVID19 vaccination, with the highest risks seen in young males following a second vaccine dose.  Similar findings have been reported by other investigators working with CDC health scientists.  RSI investigators noted that the risk of myopericarditis is appreciably higher in individuals with COVID 19 than the risk associated with vaccination.

More RSI News

Climate change modelling for the Bow River watershed

June 29, 2016

Following up on the recommendations put forth by the Expert Management Panel on River Flood Mitigation, the Environmental and Safety Management (ESM) and Water Resources (WS)…

QuarterWatch analyzes MedWatch Reports

June 29, 2016

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs…

Climate change modelling for the Bow River watershed

June 29, 2016

Developing a suite of watershed-scale climate models.

QuarterWatch analyzes MedWatch Reports

June 29, 2016

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs…